Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring
Go back to Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring| (NASDAQ: NTRA) | Delayed: 248.61 +13.85 (5.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $234.76 | 52 Week High | $13.80 | |||
| Open | $243.00 | 52 Week Low | $6.52 | |||
| Day High | $248.64 | P/E | N/A | |||
| Day Low | $239.00 | EPS | $0.00 | |||
| Volume | 99,755 | |||||

